COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY IL-2 FUSION PROTEIN AND A B-CELL BINDING MOLECULE, B-CELL PROVISIONS AND / OR THEIR CARCINOGENIC COMPOSTER
- 专利权人:
- PHILOGEN S.P.A.
- 发明人:
- NERI, DARIO,MENSSEN, HANS DIETRICH,MENRAD, ANDREAS,SCHLIEMANN, CHRISTOPH
- 申请号：
- AT08075044
- 公开号：
- AT548052T
- 申请日:
- 2008.01.17
- 申请国别(地区):
- AT
- 年份:
- 2012
- 代理人:
- 摘要：
- The present invention relates to a combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart and uses thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Combination of an anti-fibronectin-il-2 edb fusion protein and a b-cell binding molecule, b-cell progenitors and / or their cancerous counterpart
- Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart
- COMBINATION OF AN ANTI-EDB FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART
- Combination of an anti-EDb fibronectin antibody-IL-2 fusion protein, and a molecule binding to B cells, B cell progenitors and/or their cancerous counterpart
- ASSOCIATION D'UNE PROTEINE DE FUSION IL-2-ANTICORPS ANTI-EDB DE FIBRONECTINE, ET D'UNE MOLECULE SE LIANT AUX LYMPHOCYTES B, AUX CELLULES PROGENITRICES DES LYMPHOCYTES B ET/OU LEUR CONTREPARTIE CANCEREUSE
